Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
FRLN was delisted on the 16th of February, 2024.
19 hedge funds and large institutions have $144M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.
5% less funds holding
Funds holding: 20 → 19 (-1)
34% less capital invested
Capital invested by funds: $217M → $144M (-$72.6M)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
CHI Advisors
New York
|
+$374K |
| 2 |
Axa
Paris,
France
|
+$68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.13M |
| 2 |
OCM
Ovata Capital Management
Hong Kong
|
-$274K |
| 3 |
ABG
Ally Bridge Group
New York
|
-$257K |
| 4 |
Millennium Management
New York
|
-$82.3K |
| 5 |
Morgan Stanley
New York
|
-$71.8K |
FRLN Hedge Fund Activity: Q1 2021 in Review
19 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q1 2021, worth a combined $144M — down 34% from $217M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FRLN and 0 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 2 added.
The largest buyer was CHI Advisors, adding an estimated $374K. The largest seller was Wellington Management Group, cutting an estimated $2.13M.
- 19 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q1 2021, down from 20 in Q4 2020.
- Funds reported $144M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q1 2021, down 34% quarter-over-quarter.
- 0 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q1 2021 and 1 closed out, a net change of -1 holder.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q1 2021 was CHI Advisors, an estimated $374K added.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q1 2021 was Wellington Management Group, an estimated $2.13M sold.
Based on aggregated 13F filings for Q1 2021.